Bayern Munich’s dynamic winger Jamal Musiala has opened up about a recent medical condition that caused him to lose consciousness on the pitch for the second time within a four‑day span. The 23‑year‑old German international explained that doctors have diagnosed him with brief, treatable absence seizures, a form of neurological disturbance that can briefly interrupt brain activity and lead to sudden collapses.
Musiala first experienced the episode on Tuesday evening during a friendly match against FC Heidenheim, falling to the ground just eight minutes after entering the game as a substitute. This incident came only two days after a similar episode during Bayern’s pre‑season friendly with RB Leipzig on Saturday. In both cases, the young star’s teammates and medical staff responded quickly, and he was able to receive immediate care on the field.
In a candid Instagram post, Musiala thanked fans for their outpouring of concern and clarified the nature of his condition. He wrote, “First things first, I am doing well.
I am incredibly grateful for your messages and your support!” He went on to explain that the seizures are “brief, temporary – but treatable – absence seizures resulting from a neurological dysfunction.” According to medical experts, these types of seizures are generally short‑lived, lasting only a few seconds, and can be managed with medication and lifestyle adjustments. While they can cause a sudden loss of consciousness that appears alarming to onlookers, they do not typically pose a lasting threat to an athlete’s overall health when properly monitored. Musiala emphasized that, despite the unsettling visual of the collapses, there is no long‑term danger to his wellbeing. He said, “There is no further health risk involved.
In close consultation and regular contact with the experts, it was my personal wish to face this challenge; with the medical clearance of the neurologists, I want to continue doing what helps my recovery most: simply living my life and pursuing my passion for playing football.” The Bayern medical team, together with external neurologists, have given him the green light to keep training and competing, provided he follows the prescribed treatment plan and maintains regular check‑ups. The winger’s statement also highlighted the importance of a strong support network.
He thanked Bayern Munich, his family, friends, and the club’s medical staff for standing by him during this uncertain period. “FC Bayern and my personal support network are right by my side, helping me through this,” he wrote. Musiala’s openness about his health issue is notable in a sport where players often keep medical matters private.
By sharing his diagnosis, he hopes to demystify the condition and reassure supporters that he remains in good hands. From a broader perspective, Musiala’s situation sheds light on the challenges athletes can face with hidden health conditions that may not be immediately apparent during routine physical examinations.
Absence seizures, sometimes called petit mal seizures, are more commonly associated with children and adolescents, but they can also affect adults, including high‑performance athletes. Symptoms can include a brief lapse in awareness, staring spells, or sudden collapses, all of which can be mistaken for fatigue or a simple faint. Prompt medical evaluation is essential to differentiate these episodes from other causes and to implement appropriate treatment. In terms of his football career, Musiala remains optimistic and eager to contribute to Bayern’s upcoming season.
He expressed that the best way for him to recover is to stay engaged with the sport he loves, stating, “What helps me most on this journey is continuing to chase victories and titles with my team and with your amazing support.” This mindset aligns with modern sports medicine, which often encourages athletes to maintain a sense of normalcy and purpose while undergoing treatment, rather than isolating them completely. Fans can take comfort in the fact that Musiala is under continuous observation by neurologists who are monitoring his response to medication and any potential triggers. The club has assured supporters that they will keep the public informed of any significant updates, while also respecting Musiala’s wish for privacy.
He requested that the details of his condition be shared only with his close circle, the club, and medical professionals, underscoring his desire to keep the focus on his performance rather than his health challenges. Looking ahead, Musiala’s case may encourage other athletes and clubs to proactively screen for neurological issues, especially when unexplained fainting or collapses occur. Early detection and treatment can prevent more serious complications and help players return to full fitness more quickly.
As Bayern prepares for the new campaign, the winger’s determination to push forward serves as an inspiring example of resilience in the face of adversity. In summary, Jamal Musiala has been diagnosed with treatable absence seizures that caused two recent on‑field collapses. He has received clearance from neurologists to continue playing, is following a medical regimen, and remains positive about his future with Bayern Munich. His transparent communication aims to alleviate fan concerns, educate the public about the condition, and emphasize that there is no long‑term health risk as long as he adheres to his treatment plan.
The football community can look forward to seeing Musiala back on the pitch, striving for victories alongside his teammates, while his health remains closely monitored by a dedicated team of professionals.